 |
Tangir J, Smith B, Higgins
SA, Schwartz PE (2006). Gynecologic Oncology: Therapy
(Chapter 32). In
R.A.Lobo (Ed.), Obstetrics and Gynecology-2006. (pp 1-30).
Castle Connolly Graduate Medical
Publishing, LTD. New York, NY.
|
|
Seli E, Tangir J (2005). Fertility Preservation Options
for Female Patients with Malignancies. Curr Opin
Obstet Gynecol; 17:299-308.
|
|
Schwartz PE, Tangir J, Azodi M (2005).
Hormone Replacement Therapy in Women with a Prior
Diagnosis of Ovarian Cancer. CME Journal of Gynecologic
Oncology. 5:2.
|
|
O’Malley DM, Azodi M, Makkenchery
A, Tangir J, McAlpine J, Kelly M, Schwartz PE, Rutherford
TJ (2005). Weekly Topotecan in Heavily Pretreated Patients
with Recurrent Epithelial Ovarian
Carcinoma. Gynecol Oncol; 98:242-248
|
|
Tangir J, Bonafe N, Gilmore-Hebert
M, Henegariu O, Chambers SK. (2004). SGK1, a Potential
Regulator
of c-fms Related Breast Cancer Aggressiveness. Clin &
Exp Metastasis; 21, 477-483
|
|
Tangir J, Schwartz PE (2003) Fertility
preservation in germ cell tumors of the ovary. CME Journal
of
Gynecologic Oncology. 8:117-120.
|
|
Tangir J, Zelterman D, Ma W &
Schwartz PE (2003). Reproductive function after conservative
surgery
and chemotherapy for malignant germ cell tumors of the
ovary. Obstet Gynecol;101, 251-257
|
|
Tangir J, Schwartz PE (2002). Embryonal
carcinoma: diagnosis and management during pregnancy and
fertility after the diagnosis. CME Journal of Gynecologic
Oncology 7, 225-227.
|
|
Tangir, J. (2001). Infection and
Pregnancy Loss. In M. Berman (Ed.), Parenthood Lost. Healing
the Pain
after Miscarriage, Stillbirth, and Infant Death (pp. 168-179).
Wesport: Bergin & Garvey.
|
|
Wertheim, I., Tangir, J., Muto, M.
G., Welch, W. R., Berkowitz, R. S., Chen, W. Y., &
Mok, S. C. (1996).
Loss of heterozygosity of chromosome 17 in human borderline
and invasive epithelial ovarian tumors.
Oncogene., 12(10), 2147-2153.
|
|
Tangir, J., Muto, M. G., Berkowitz, R. S., Welch, W.
R., Bell, D. A., & Mok, S. C. (1996). A 400 kb
novel deletion unit centromeric to the BRCA1 gene in sporadic
epithelial ovarian cancer. Oncogene.,
12(4), 735-740.
|
|
Tangir, J., Loughridge,
N. S., Berkowitz, R. S., Muto, M. G., Bell, D. A., Welch,
W. R., & Mok, S. C.
(1996). Frequent microsatellite instability in epithelial
borderline ovarian tumors. Cancer Research.,
56(11), 2501-2505.
|
|
Muto, M. G., Cramer, D. W., Tangir,
J., Berkowitz, R., & Mok, S. (1996). Frequency of
the BRCA1
185delAG mutation among Jewish women with ovarian cancer
and matched population controls. Cancer
Research., 56(6), 1250-1252.
|
Abstracts & Presentations
|
New Techniques in Minimally
Invasive and Robotic Surgery for Patients with Gynecologic
Cancer
(May 2008). Invited Speaker. Memorial Healthcare System.
Dept. of Ob/Gyn. Pembroke Pines, Florida
|
|
Robotic Surgery in Gynecology. (March 2008). Invited
Speaker. Venezuelan Society of Gynecology and
Obstetrics. 24th Annual Congress. Maracaibo, Venezuela
|
|
Laparoscopy in the Management of
Cervical Cancer (March 2008). Invited Speaker. Venezuelan
Society
of Gynecology and Obstetrics. 24th Annual Congress. Maracaibo,
Venezuela
|
|
Update in the Diagnosis and Management
of Ovarian Cancer (May 2007). Invited Speaker. Dept of
Surgery. Grand Rounds. Mount Sinai Medical Center. Miami
Beach, FL
|
|
Update in the Prevention and Early
Diagnosis of Gynecologic Malignancies (September 2006).
Invited
speaker. Dept. of Internal Medicine Grand Rounds. Mount
Sinai Medical Center. Miami Beach, FL
|
|
Symposium: Minimally Invasive Surgery
in Gynecologic Oncology. (June 2006). Co-Director and
Speaker.
Miami, Fl
|
|
Minimally Invasive Surgery in the
Management of Gynecologic Cancer (April 2006). Invited
Speaker.
Dept of Surgery. Grand Rounds. Cleveland Clinic. Weston,
Fl.
|
|
Update in Gynecologic Oncology (January
2006). Invited speaker. Dept. of Internal Medicine Grand
Rounds. Mount Sinai Medical Center. Miami Beach, FL
|
|
Early Diagnosis of Gynecologic Malignancies
(October 2005). Invited speaker. Aventura Comprehensive
Cancer Center. Aventura, FL
|
|
Fertility Preserving Surgery in the
Management of Gynecologic Malignancies. (April 2005).
Invited
speaker. Baptist Health. South Miami Hospital. Miami,
FL
|
|
Tangir J, Chambers SK, Zheng W, Salenius
S, Schwartz PE O'Malley D, Rutherford TJ. (March 2005).
Clinical Implications of Pelvic Lymph Node Micrometastasis
in Early Stage Cervical Cancer. Paper
presented at: Society of Gynecologic Oncology, 36th Annual
Meeting; Miami, FL.
|
|
Fertility Preserving Surgery in the
Management of Gynecologic Malignancies. (January 2005).
Invited
speaker. Mount Sinai Medical Center. Miami Beach, FL.
|
|
Morosky C, O’Malley, D, Tangir
J; Zelkowitz S. Azodi M, Chambers SK, Schwartz PE, Rutherford
TJ
(June 2004). Carboplatin/Paclitaxel as Adjuvant Therapy
for Stage III Endometrial Adenocarcinoma.
Paper presented at: American Society of Clinical Oncology.
Annual Meeting. New Orleans, LA.
|
|
Fertility Preserving Surgery in the
Management of Gynecologic Malignancies. (March 2004).
Invited
speaker. Venezuelan Society of Gynecology and Obstetrics.
20th Annual Congress. Caracas, Venezuela
|
|
Advances in the surgical management
of cervical cancer. (March 2004). Invited speaker. Venezuelan
Society of Gynecology and Obstetrics. 20th Annual Congress.
Caracas, Venezuela
|
|
Tangir J, Schwartz PE.
(February 2004). Gynecologic Cancer Incidence Patterns
among Hispanics in the United States. Paper presented
at: Society of Gynecologic Oncology, 35th Annual Meeting;
San Diego, CA
|
|
Tangir J, Bonafe N., & Chambers
SK. (March 2003). SGK1, a Potential Regulator of c-fms
Related Breast Cancer Aggressiveness. Paper presented
at: Society of Gynecologic Investigation, 50th Annual
Scientific Meeting; Washington, DC
|
|
Tangir J, Bonafe N, Chambers SK. (January 2003) Glucocorticoid-Induced
Genetic Alterations in Breast Cancer Cells. Paper presented
at: Society of Gynecologic Oncology, 34th Annual Meeting;
New Orleans, LA.
|
|
Advances in the Management of Endometrial
Cancer. (September 2002). Invited speaker Grand Rounds.
Dept Ob/Gyn. Hospital Vargas. Caracas, Venezuela
|
|
Advances in the Management of Ovarian Cancer.
(September 2002). Invited speaker. Medical Society. Centro
Medico de Caracas, Caracas, Venezuela
|
|
Tangir, J., Bonafe, N., & Chambers,
SK. (June 2002). Glucocorticoid-Induced Genetic Alterations
in Breast Cancer Cell Lines. Paper presented at the New
England Association of Gynecologic Oncologist. 22nd Annual
Meeting, Martha's Vineyard, Massachusetts.
|
|
Advances in the Management of Ovarian
Cancer (May 2002) Invited speaker. Grand Rounds. Dept
of
Ob/Gyn. Hospital Vargas. Caracas, Venezuela
|
|
Tangir, J., & Schwartz, P. (February
2000). Reproductive Function after Conservative Surgery
Followed
Routinely by Chemotherapy for Malignant Ovarian Germ Cell
Tumors. Paper presented at the Society of
Gynecologic Oncologist. 31st Annual Meeting, San Diego,
California.
|
|
Tangir, J., Muto, M. G., Berkowitz,
R. S., Welch, W. R., Bell, D. A., & Mok, S. (February
1996). A novel deletion unit centromeric to the BRCA1
gene in sporadic epithelial ovarian cancer. Paper presented
at the Society of Gynecologic Oncologist. 27th Annual
Meeting, New Orleans, Louisiana.
|
|
Edelson, M. I., Tangir, J., Welch,
W. R., Bell, D. A., Berkowitz, R. S., & Mok, S. (February
1996).
Deletion Mapping of chromosome 7q in borderline and invasive
epithelial ovarian tumors. Paper presented
at the Society of Gynecologic Oncologist. 27th Annual
Meeting, New Orleans, Louisiana.
|
|
Tangir, J., Muto, M. G., Berkowitz,
R. S., & Mok, S. (June 1995). Allelic loss of the
BRCA1 gene in human sporadic invasive and borderline ovarian
epithelial tumors. Paper presented at the New England
Association of Gynecologic Oncologist. 15th Annual Meeting,
Williamstown, Massachusetts.
|
|
Wertheim, I., Tangir, J., Muto, M.
G., Welch, W. R., Berkowitz, R., & Mok, S. (June 1995).
Loss of
heterozygosity and microsatellite instability of chromosome
17 in human borderline and invasive epithelial
ovarian tumors. Paper presented at the New England Association
of Gynecologic Oncologist. 15th
Annual Meeting, Williamstown, Massachusetts.
|
|
